Akorn, Inc. Responds to FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl (Business Wire via Yahoo! Finance)
LAKE FOREST, Ill.----Akorn, Inc. today provided the following response regarding FDA s draft guidance on vancomycin hydrochloride capsules.

American Academy Of Dermatology Issues Statement On FDA Report To Congress About Labeling Information On Indoor ... (Medical News Today)
The American Academy of Dermatology (Academy) issued a statement in response to the Food and Drug Administration's Report to Congress about labeling information on the relationship between the use of indoor tanning devices and development of skin cancer or other skin damage. The FDA report was submitted pursuant to Section 230 of the Food and Drug Administration Amendments Act of 2007.